Health In Tech Inc(HIT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 4:00 PM ET (Korea 10/31 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.07 | Insider Own | 73.35% | Shs Outstand | 53.9M | Perf Week | 2.67% |
| Market Cap | 0.04B | Forward P/E | - | EPS next Y | 98.08% | Insider Trans | -0.09% | Shs Float | 17.4M | Perf Month | -21.78% |
| Enterprise Value | 0.03B | PEG | - | EPS next Q | -0.05 | Inst Own | 7.23% | Short Float | 2.43% | Perf Quarter | -49.36% |
| Income | -0.00B | P/S | 1.15 | EPS this Y | -966.66% | Inst Trans | 57.35% | Short Ratio | 2.41 | Perf Half Y | -62.75% |
| Sales | 0.03B | P/B | 1.94 | EPS next 5Y | - | ROA | -14.79% | Short Interest | 0.42M | Perf YTD | -63.69% |
| Book/sh | 0.3 | P/C | 5.79 | EPS past 3/5Y | 145.52% - | ROE | -21.96% | 52W High | -81.44% ($3.11) | Perf Year | -77.88% |
| Cash/sh | 0.1 | P/FCF | - | Sales past 3/5Y | 79.42% - | ROIC | -20.18% | 52W Low | 15.46% ($0.50) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -362.1% | Gross Margin | 53.93% | Volatility(W/M) | 18.37% 12.28% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 0.96 | Sales Y/Y TTM | 22.98% | Oper. Margin | -17.22% | ATR (14) | 0.08 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.17 | EPS Q/Q | -453.98% | Profit Margin | -12.03% | RSI (14) | 37.13 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.17 | Sales Q/Q | -13.5% | SMA20 | -11.97% ($0.66) | Beta | 2.86 | Target Price | $3.12 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/11/12 | SMA50 | -28.48% ($0.81) | Rel Volume | 0.14 | Prev Close | $0.61 |
| Employees | 91 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -49.81% 4.08% | SMA200 | -49.81% ($1.16) | Avg Volume(3M) | 0.18M | Price | $0.58 |
| IPO | 2024/12/23 | Option/Short | No/Yes | Trades | 778 | Volume | 25,147 | Change | -5.61% |
🛡️ This next-generation U.S. insurtech company provides customized health insurance solutions for small and medium-sized businesses (SMBs) using artificial intelligence (AI) technology. Through its proprietary "eDIYBS" platform, it dramatically shortens the complex process of insurance design and enrollment, leading digital innovation in the health insurance market.
Over the past 1 year, on the lower side
81% below its 1-year high.
Traded less than usual. That is 14% of its average volume.
Next earnings report: November 12
11 days to go.
HIT has a sound balance sheet but weak earning power
Of every $100 in sales, $17.22 is lost.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -966.7% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $115. Peers typically go for $123.
Tap to view numbers
Results came in about as expected
Generally in line with estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 7.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #169 of 225 in the industry
Based on market cap of $38M.
FRMM#167 Forum Markets Inc $46M PER - 
PHUN#168 Phunware Inc $38M PER - HIT#169 Health In Tech Inc $38M PER - 
CRGO#170 Freightos Ltd $35M PER - 
ATHR#171 Aether Holdings Inc $32M PER - 
FAQ
What kind of company is HIT?
HIT belongs to the Technology sector and operates in the Software - Application industry.
What is the market cap of HIT?
The market cap of HIT is approximately $38M, ranking 4,981 within its sector.
What is the 52-week high and low for HIT?
HIT has recorded a 52-week high of $3.11 and a low of $0.50.
